156 related articles for article (PubMed ID: 36816742)
21. Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma.
Liu B; Liu Z; Feng C; Li C; Zhang H; Li Z; Tu C; He S
Front Endocrinol (Lausanne); 2022; 13():987942. PubMed ID: 36313774
[TBL] [Abstract][Full Text] [Related]
22. Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma.
Sun Y; Wu J; Yuan Y; Lu Y; Luo M; Lin L; Ma S
Front Cell Dev Biol; 2021; 9():673838. PubMed ID: 34124058
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
Front Immunol; 2022; 13():997765. PubMed ID: 36275664
[TBL] [Abstract][Full Text] [Related]
24. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
Yan Y; Wang X; Liu C; Jia J
BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
[TBL] [Abstract][Full Text] [Related]
25. Interaction gene set between osteoclasts and regulatory CD4
Li F; Tang H; Luo X; Li X; Luo K; Liu S; Liang J; Liao S; Zhong C; Zhan X; Wei Q; Feng W; Liu Y
Cancer Sci; 2023 Jul; 114(7):3014-3026. PubMed ID: 37150900
[TBL] [Abstract][Full Text] [Related]
26. EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma Based on an Integrative Analysis.
Dai Z; Liu Z; Yang R; Cao W; Ji T
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830696
[TBL] [Abstract][Full Text] [Related]
27. ADAM19 and TUBB1 Correlate with Tumor Infiltrating Immune Cells and Predicts Prognosis in Osteosarcoma.
Wang J; Gong M; Xiong Z; Zhao Y; Xing D
Comb Chem High Throughput Screen; 2023; 26(1):135-148. PubMed ID: 35388751
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients.
Yuan Y; Zhu Z; Lan Y; Duan S; Zhu Z; Zhang X; Li G; Qu H; Feng Y; Cai H; Song Z
Front Immunol; 2021; 12():659444. PubMed ID: 34040608
[TBL] [Abstract][Full Text] [Related]
29. Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma.
Zong Y; Cao Y; Zhang D; Guan X; Zhang F; Shen Z; Yin F
Sci Rep; 2023 Jun; 13(1):9118. PubMed ID: 37277499
[TBL] [Abstract][Full Text] [Related]
30. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract][Full Text] [Related]
31. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
Wang H; Li J; Li X
Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
[TBL] [Abstract][Full Text] [Related]
32. Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients.
Mazzaschi G; Minari R; Zecca A; Cavazzoni A; Ferri V; Mori C; Squadrilli A; Bordi P; Buti S; Bersanelli M; Leonetti A; Cosenza A; Ferri L; Rapacchi E; Missale G; Petronini PG; Quaini F; Tiseo M
Lung Cancer; 2020 Oct; 148():1-11. PubMed ID: 32768804
[TBL] [Abstract][Full Text] [Related]
33. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
34. Single-cell RNA sequencing reveals the immune microenvironment landscape of osteosarcoma before and after chemotherapy.
Liu Y; Lin Y; Liao S; Feng W; Liu J; Luo X; Wei Q; Tang H
Heliyon; 2024 Jan; 10(1):e23601. PubMed ID: 38332885
[TBL] [Abstract][Full Text] [Related]
35. A robust CD8
Feng J; Xu L; Zhang S; Geng L; Zhang T; Yu Y; Yuan R; He Y; Nan Z; Lin M; Guo H
Front Immunol; 2022; 13():993187. PubMed ID: 36119068
[TBL] [Abstract][Full Text] [Related]
36. Identification of two immune subtypes in osteosarcoma based on immune gene sets.
Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z
Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161
[TBL] [Abstract][Full Text] [Related]
37. Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration.
Chen Z; Li L; Li Z; Wang X; Han M; Gao Z; Wang M; Hu G; Xie X; Du H; Xie Z; Zhang H
Cancer Cell Int; 2022 Feb; 22(1):78. PubMed ID: 35151325
[TBL] [Abstract][Full Text] [Related]
38. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
39. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
Wu ZY; Shi ZY
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
[TBL] [Abstract][Full Text] [Related]
40. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
